The identified PIK3CA mutations have been previously reported in other patients with PROS [22, 23], and the KRAS and TEK mutations in patients with vascular malformation [24, 25], but the MAP2K3 and TBC1D4 mutations have not been previously reported. This evidence concerns the gene MAP2K3 and vascular malformation.